Ftse Mib
34.660,38
-0,50%
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
NASDAQ
17.133,13
-0,23%
Bitcoin
69.284,96
-0,05%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ CorMedix Inc (CRMD) CorMedix Inc (CRMD) Notizie

CRMD

CorMedix (CRMD)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CRMD
DataOraFonteTitoloSimboloCompagnia
06/06/202414:30GlobeNewswire Inc.CorMedix Inc. Announces CMS Grants Pass-Through Status to DefencathNASDAQ:CRMDCorMedix Inc
23/05/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CRMDCorMedix Inc
13/05/202422:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRMDCorMedix Inc
09/05/202423:06Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CRMDCorMedix Inc
09/05/202414:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRMDCorMedix Inc
09/05/202413:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRMDCorMedix Inc
19/04/202414:30GlobeNewswire Inc.CorMedix Inc. Announces CMS Grants TDAPA to DefenCathNASDAQ:CRMDCorMedix Inc
15/04/202414:30GlobeNewswire Inc.CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)NASDAQ:CRMDCorMedix Inc
12/03/202412:30GlobeNewswire Inc.CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:CRMDCorMedix Inc
18/01/202422:53Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:CRMDCorMedix Inc
14/12/202322:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRMDCorMedix Inc
14/11/202322:05GlobeNewswire Inc.CorMedix Inc. Reports Third Quarter and Nine Month 2023 Financial Results and Provides Business UpdateNASDAQ:CRMDCorMedix Inc
11/10/202314:30GlobeNewswire Inc.CorMedix Inc. Announces Abstract Presentation at Upcoming IDWeek ConferenceNASDAQ:CRMDCorMedix Inc
13/09/202323:26Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:CRMDCorMedix Inc
13/09/202323:25Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CRMDCorMedix Inc
13/09/202323:20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CRMDCorMedix Inc
08/09/202314:30GlobeNewswire Inc.CorMedix Inc. Announces Publication of Phase 3 LOCK IT-100 Study Data in the Clinical Journal of The American Society of NephrologyNASDAQ:CRMDCorMedix Inc
30/08/202314:00GlobeNewswire Inc.CorMedix Inc. Announces Issuance of U.S. Patent Covering Lead Product DefencathNASDAQ:CRMDCorMedix Inc
08/08/202313:30GlobeNewswire Inc.CorMedix Inc. Reports Second Quarter and Six Month 2023 Financial Results and Provides Business UpdateNASDAQ:CRMDCorMedix Inc
30/06/202322:38Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CRMDCorMedix Inc
29/06/202304:57GlobeNewswire Inc.CorMedix Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:CRMDCorMedix Inc
28/06/202323:14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CRMDCorMedix Inc
28/06/202322:07GlobeNewswire Inc.CorMedix Inc. Announces Proposed Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:CRMDCorMedix Inc
21/06/202314:43Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRMDCorMedix Inc
21/06/202314:30GlobeNewswire Inc.CorMedix Inc. Announces FDA Acceptance of Resubmission of New Drug Application for DefenCathNASDAQ:CRMDCorMedix Inc
15/06/202314:30GlobeNewswire Inc.Cormedix Inc. Announces Strategic Initiative With Boston Medical Center to Reduce Health Disparities in Patients at Risk for Bloodstream InfectionsNASDAQ:CRMDCorMedix Inc
19/05/202322:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRMDCorMedix Inc
19/05/202300:26Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CRMDCorMedix Inc
16/05/202313:00GlobeNewswire Inc.CorMedix Inc. Announces Resubmission of New Drug Application for DefenCathNASDAQ:CRMDCorMedix Inc
15/05/202322:05GlobeNewswire Inc.CorMedix Inc. Reports First Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:CRMDCorMedix Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CRMD

La tua Cronologia

LSE
95YU
Finnvera 28
LSE
40XV
Paragon 12 A1s
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network